awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33404543-102184A6-CAA5-4183-B815-F5D882BDD8A5
Q33404543-102184A6-CAA5-4183-B815-F5D882BDD8A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404543-102184A6-CAA5-4183-B815-F5D882BDD8A5
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors.
P2860
Q33404543-102184A6-CAA5-4183-B815-F5D882BDD8A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404543-102184A6-CAA5-4183-B815-F5D882BDD8A5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
64fd4c0592364929bbb8bf64a80ab2051c0c6f6e
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.